Literature DB >> 32014434

Long-acting reversible contraceptive (LARCs) methods.

Luis Bahamondes1, Arlete Fernandes2, Ilza Monteiro2, M Valeria Bahamondes3.   

Abstract

Unplanned pregnancy (UP) is a public health problem, which affects millions of women worldwide. Providing long-acting reversible contraceptive (LARC) methods is an excellent strategy to avoid or at least reduce UP, because the effectiveness of these methods is higher than other methods, and is indeed comparable to that of permanent contraception. As the initial introduction of the inert plastic intrauterine device (IUD) and of the six-rod implant, pharmaceutical companies have introduced a copper IUD (Cu-IUD), different models of levonorgestrel-releasing intrauterine system (LNG IUS), and one and two-rod implants, which certainly improved women's LARC options. The main characteristic of LARCs is that they provide high contraceptive effectiveness with a single intervention, and that they can be used for a long time. Emerging evidence from the last few years has demonstrated that it is possible to extend the use of the 52 mg LNG IUS and of the etonogestrel-implant beyond five- and three years, respectively, which adds new value to these LARCs.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Contraception; Copper intrauterine device; LARCs; Levonorgestrel-releasing intrauterine system; Long acting contraceptives; Subdermal implants

Mesh:

Substances:

Year:  2019        PMID: 32014434     DOI: 10.1016/j.bpobgyn.2019.12.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  9 in total

1.  Ectopic Intrauterine Device Revealed by Ureteral Colic in a 37-Week Pregnant Woman: Case Report.

Authors:  Alexandra Matei; Mihai Cornel Traian Dimitriu; Irina Pacu; Crîngu Ionescu
Journal:  Healthcare (Basel)       Date:  2022-06-08

2.  What are the prospects for the hormonal IUD in the public sector? A mixed-method study of the user population in Zambia.

Authors:  Aurélie Brunie; Megan Lydon; Kayla Stankevitz; Namwinga Chintu; Claire Brennan; Kendal Danna; Kate H Rademacher
Journal:  BMC Womens Health       Date:  2022-05-15       Impact factor: 2.742

Review 3.  Beyond the pill: contraception and the prevention of hereditary ovarian cancer.

Authors:  Yue Yin Xia; Joanne Kotsopoulos
Journal:  Hered Cancer Clin Pract       Date:  2022-06-06       Impact factor: 2.164

4.  Are myths surrounding long-acting reversible contraception the reason for a huge unmet need for spacing pregnancies?

Authors:  Monika Anant; Kajal Sinha; Ananya Agrawal
Journal:  J Family Med Prim Care       Date:  2021-12-27

5.  Factors affecting utilization of long-acting reversible contraceptives among sexually active reproductive-age women in the pastoral community of Northeast Ethiopia: A community-based cross-sectional study.

Authors:  Kusse Urmale Mare; Ezana Abrha; Ebrahim Mohammed Yesuf; Setognal Birara Aychiluhm; Abay Woday Tadesse; Simeon Meskele Leyto; Kebede Gemeda Sabo; Getahun Fentaw Mulaw; Osman Ahmed Mohammed; Oumer Abdulkadir Ebrahim
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

6.  Barriers for multiparous women to using long-term contraceptive methods in Southeast Asia: case study in Philippines and Indonesia.

Authors:  Agung Dwi Laksono; Nikmatur Rohmah; Hario Megatsari
Journal:  BMC Public Health       Date:  2022-07-27       Impact factor: 4.135

Review 7.  Robot-Assisted Tubal Reanastomosis after Sterilization: A Choice for Family Planning.

Authors:  Arwa Salehjawich; Veronika Günther; Zino Ruchay; Mazhar Salim Al Zoubi; Juhi Dhanawat; Nicolai Maass; Johannes Ackermann; Julian Pape; Ibrahim Alkatout
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

Review 8.  Safety and Benefits of Contraceptives Implants: A Systematic Review.

Authors:  Morena Luigia Rocca; Anna Rita Palumbo; Federica Visconti; Costantino Di Carlo
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-08

Review 9.  The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review.

Authors:  John T Kanazawa; Parya Saberi; John A Sauceda; Karine Dubé
Journal:  AIDS Res Hum Retroviruses       Date:  2020-12-07       Impact factor: 2.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.